Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001079973-25-001318
Filing Date
2025-08-14
Accepted
2025-08-14 19:08:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 6469
  Complete submission text file 0001079973-25-001318.txt   8502
Mailing Address 642 NEWTOWN YARDLEY ROAD NEWTOWN PA 18940
Business Address 642 NEWTOWN YARDLEY ROAD NEWTOWN PA 18940 215-944-6100
HELIUS MEDICAL TECHNOLOGIES, INC. (Subject) CIK: 0001610853 (see all company filings)

EIN.: 364787690 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-89397 | Film No.: 251221807
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 161A SHEDDEN ROAD ONE ARTILLERY COURT P.O. BOX 10085 GRAND CAYMAN E9 KY1-1001
Business Address 161A SHEDDEN ROAD ONE ARTILLERY COURT P.O. BOX 10085 GRAND CAYMAN E9 KY1-1001 646-688-5654
L1 Capital Global Opportunities Master Fund, Ltd. (Filed by) CIK: 0001702202 (see all company filings)

EIN.: 981241877 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A